Scientific Program

Conference Series Ltd invites all the participants across the globe to attend International Conference on Psoriasis and Skin Specialists Meeting Dallas,Texas, USA.

Day 2 :

Keynote Forum

Pooya Khan Mohammad Beigi

Misdiagnosis Association, USA

Keynote: Effect of psoriasis on patient’s quality of life

Time : 09:30-10:15

OMICS International Psoriasis-2016 International Conference Keynote Speaker Pooya Khan Mohammad Beigi  photo
Biography:

Pooya Khan Mohammad Beigi is a Clinical Research Fellow at the Child & Family Research Institute affiliated with the University of British Columbia, Canada and the President/Owner of the NWM Medical Clinic, Canada. He is also the Founder/CEO of Misdiagnosis Association and Society, USA and Founder/CEO of Father Medical Charity, Canada. He is the author of several books in the medical field including Acrodermatitis Enteropathica: A Clinician's Guide (2015), A Clinician's Guide to Mycosis Fungoides (2016), A Clinician's Guide to Pemphigus Vulgaris (2016), A Clinician's Guide to Psoriasis (2017) and A Clinician's Guide to Alopecia Areata (2017).

Abstract:

Objective: Aim of our study is to investigate the effect of psoriasis on different aspects of patients’ life and show the psychological burden of this disease, recognition of high risk people and overall attempting for enhancement of patients’ quality of life.

Method: Present study is an analytical cross sectional study performed by demographic and DLQI questionnaires. Patients responded to the questionnaire containing personal information (age, gender, education, address, marital status, disease duration and extent) and also the questions on application of biological drugs, history of disease recurrence and history of systemic drug use. They also answer to life quality questionnaire; finally, dermographic data including involvement sites and visible or not visible lesions were examined and recorded.

Results: DLQI variable had normal distribution, the average score was 6.51 and its standard deviation was 6.66. Its range varies from 0 to 28. It must be noted that the higher the score, the lower the life quality. The studied variables did not have any significant relationship with life quality. Also the correlation between the age and disease severity, life quality and age and also the life quality and disease severity were not significant.

Conclusion: It seems that the life quality of patients is under the influence of the disease itself rather than its severity, treatment and the variables related to disease symptoms